Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels
- PMID: 34174111
- PMCID: PMC8444892
- DOI: 10.1111/bcp.14953
Challenge in treating COVID-19 associate pulmonary aspergillosis: Supratherapeutic voriconazole levels
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
References
-
- Elewa H, El‐Mekaty E, El‐Bardissy A, Ensom MH, Wilby KJ. Therapeutic drug monitoring of voriconazole in the management of invasive fungal infections: a critical review. Clin Pharmacokinet. 2015;54(12):1223‐1235. - PubMed
-
- Park WB, Kim NH, Kim KH, et al. The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. Clin Infect Dis. 2012;55(8):1080‐1087. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
